Ming-yi Chung is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of genetics, particularly in the study of spinocerebellar ataxia type 1. His work has led to the development of innovative methods for diagnosing this genetic condition.

Latest Patents

Ming-yi Chung holds 2 patents related to his research. His latest patents include a gene sequence for spinocerebellar ataxia type 1 and a method for diagnosis. The first patent provides an isolated DNA molecule of the autosomal dominant spinocerebellar ataxia type 1 gene, located within the short arm of chromosome 6. This isolated DNA molecule is preferably located within a 3.36 kb EcoRI fragment, which contains about 3360 base pairs of the SCA1 gene. The isolated sequences include a CAG repeat region, where the number of CAG trinucleotide repeats (n) is ≤36, preferably n=19-36 for normal individuals. For affected individuals, n>36, preferably n≥43. The second patent also provides an isolated DNA sequence of the short arm of chromosome 6, located within the same gene, with similar specifications regarding the CAG repeat region.

Career Highlights

Ming-yi Chung is affiliated with the Regents of the University of Minnesota, where he continues to advance his research in genetics. His work has been instrumental in understanding the genetic basis of spinocerebellar ataxia type 1, contributing to both academic knowledge and potential clinical applications.

Collaborations

Ming-yi Chung has collaborated with esteemed colleagues in his field, including Laura P Ranum and Huda Y Zoghbi. These collaborations have further enriched his research and expanded the impact of his findings.

Conclusion

Ming-yi Chung's innovative work in genetic research, particularly regarding spinocerebellar ataxia type 1, showcases his dedication to advancing medical science. His contributions through patents and collaborations highlight the importance of genetic research in understanding and diagnosing complex conditions.